<p>Immune response to infection or vaccination is compromised with age. We aimed to examine associations between immune senescence, T and B cell clonal diversity and immunoglobulin G secretion in response to immune challenge in isolated peripheral blood mononuclear cells (PBMC) from people of different chronological ages. We isolated PBMC from 49 individuals categorised into &lt; 35 years and &gt; 60 years age groups. Cells were then challenged with recombinant SARS-CoV-2 spike protein or vehicle and IMMAX score was calculated for each sample from flow cytometry. Antibody response was assessed using the proxy of IgG secretion and T cell receptor and immunoglobulin framework region recombination was determined by clonality studies. We observed that individuals aged &gt; 60 years demonstrated a higher immune ‘age’ as calculated by IMMAX score (0.75 compared with 0.48 for individuals aged &lt; 35 years; p = &lt; 0.0001). Immune age negatively correlated with IgG responsivity in older individuals with recent prior exposure to SARS-CoV-2 (b = -0.01; <i>p</i> = 0.05). Higher immune age was also negatively correlated with TCR Vd + Jd receptor diversity regardless of immune challenge (b = -0.02; p = &lt; 0.0001 and b = -0.02; r<sup>2</sup> = 0.0.35; p = &lt; 0.0001 for control and exposed samples respectively). Our data demonstrate that PBMC samples from older people display a higher cellular immune age and attenuation of immune response. This suggests that future treatments targeting cellular ageing of immune cells may be a useful avenue for investigation to improve immune function in older people.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Immune age is correlated with decreased TCR clonal diversity and antibody response to SARS-CoV-2

  • Merlin Davies,
  • Hubert Denise,
  • Michael Day,
  • Sian M Henson,
  • Chris J Scotton,
  • Lorna W. Harries

摘要

Immune response to infection or vaccination is compromised with age. We aimed to examine associations between immune senescence, T and B cell clonal diversity and immunoglobulin G secretion in response to immune challenge in isolated peripheral blood mononuclear cells (PBMC) from people of different chronological ages. We isolated PBMC from 49 individuals categorised into < 35 years and > 60 years age groups. Cells were then challenged with recombinant SARS-CoV-2 spike protein or vehicle and IMMAX score was calculated for each sample from flow cytometry. Antibody response was assessed using the proxy of IgG secretion and T cell receptor and immunoglobulin framework region recombination was determined by clonality studies. We observed that individuals aged > 60 years demonstrated a higher immune ‘age’ as calculated by IMMAX score (0.75 compared with 0.48 for individuals aged < 35 years; p = < 0.0001). Immune age negatively correlated with IgG responsivity in older individuals with recent prior exposure to SARS-CoV-2 (b = -0.01; p = 0.05). Higher immune age was also negatively correlated with TCR Vd + Jd receptor diversity regardless of immune challenge (b = -0.02; p = < 0.0001 and b = -0.02; r2 = 0.0.35; p = < 0.0001 for control and exposed samples respectively). Our data demonstrate that PBMC samples from older people display a higher cellular immune age and attenuation of immune response. This suggests that future treatments targeting cellular ageing of immune cells may be a useful avenue for investigation to improve immune function in older people.